Moving Medicine Forward

Developing New Categories of Medicine

Our goal is to improve and extend the lives of patients through the development of new categories of medicine

Exploring the Brain Immune Gut (BIG) Axis

Focused on the crosstalk and biological processes associated with the brain-immune-gut interface

Giving Life to Science

Our goal is to improve and extend the lives of patients

The biopharma company of the future

Discovery Reinvented

Publications
Publications -2018-03-23
PureTech's Lymphatic Leap

PureTech Health plc is launching a new branch of inquiry into the lymphatic system following discoveries that the network extends into the brain and could be used to deliver immunotherapies directly to tissues.

FULL ARTICLE

Publications -2017-09-19
Gamma Delta T Cells Support Pancreatic Oncogenesis by Restraining αβ T Cell Activation

CD4(+) T regulatory cells (T(regs)), which express the Foxp3 transcription factor, play a critical role in the maintenance of immune homeostasis. Here, we show that in mice, T(regs) were most abundant in the colonic mucosa.

Full Article

Publications -2017-09-19
The Gut’s Clostridium Cocktail

Specific components of the microbiota—the microorganisms that normally colonize the body—can affect disease progression in mouse models of arthritis, central nervous system inflammation, diabetes, intestinal inflammation, and obesity.

Full Article
Press releases
2018-05-18
Results of Annual General Meeting

The Annual General Meeting of PureTech Health plc (LSE: PRTC) (“PureTech Health” or the “Company”), was held at 3.00 pm BST on Friday 18 May 2018. All of the resolutions proposed at the Annual General Meeting were duly passed by the shareholders on a poll. 

CONTINUE

Press releases
2018-05-09
PureTech’s Akili Raises $55 Million to Advance Digital Medicine Platform and Product Pipeline Aimed at Treating Cognitive Dysfunction

Proceeds will advance commercial and clinical stage pipeline in ADHD, multiple sclerosis, and depression

PureTech Health plc (LSE: PRTC) (“PureTech Health” or the “Company”), an advanced, clinical-stage biopharmaceutical company, announced today that its affiliate, Akili Interactive (“Akili”), has successfully completed a $55 million financing round. This financing was led by Temasek and included both new and existing strategic and institutional investors Baillie Gifford, Amgen Ventures, M Ventures (the CVC fund of Merck KGaA, Darmstadt, Germany), Jazz Venture Partners, Canepa Advanced Healthcare Funds, and Brooklands Capital Strategies.

Continue

Press releases
2018-05-02
PureTech Health Affiliate Sonde Adds Thai Lee to Board of Directors

Appointment brings extensive business growth experience to affiliate’s Board of Directors

PureTech Health plc (LSE: PRTC) (“PureTech Health” or the “Company”), an advanced, clinical-stage biopharmaceutical company, is pleased to note that Sonde Health, an affiliate of PureTech Health, today announced the appointment of Thai Lee to its Board of Directors. Ms Lee is recognised as a prominent business leader in the information technology industry and brings more than two decades of experience to Sonde’s Board of Directors.

Continue